On April 26, 2018, the China Drug Administration (CDA) released a draft guideline of implementing rules on pharmaceutical data exclusivity for public comments. The draft guideline expands the scope of ...

The Development: China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The Guidelines provide a comprehensive framework ...

State Council calls for 'value-based pricing' for innovative drugs, a move researchers said would benefit private healthcare players The State Council, China's cabinet, has published guidelines on ...

After an extensive process of consultation, the Indian Patent Office recently finalised guidelines for examination of patent applications claiming pharmaceutical inventions. These industry specific ...

Drugs for serious or life-threatening diseases can receive expedited U.S. Food and Drug Administration (FDA) review, allowing patients to receive faster access to promising new treatments. Under the ...

Just three years ago, updated cholesterol guidelines almost tripled the number of Americans for whom cholesterol-lowering statin drugs are recommended to 36 million, or one out of five adults. Statins ...

The European Medicines Agency (EMA) has released two new draft guidelines on, respectively, the quality of oral modified release products and transdermal patches. The two draft guidance documents ...

The U.S. Food and Drug Administration (FDA) announced today plans to issue technical guidelines in the next several weeks, designed to help pharmaceutical manufacturers, distributors and retailers ...

Company also updates findings related to Australian sponsored publication practices from 2000-2005 Philadelphia, PA - 4 June 2009 - Elsevier, a leading international publisher of scientific, technical ...

PHILADELPHIA (CBS) — Multiple sclerosis a leading cause of disability in the United States but new drug guidelines could help patients better manage symptoms. Advancements in medications have made it ...

Objective: To determine whether an intervention focusing clinicianattention on drug choice for hypertension treatment improvesconcordance between drug regimens and guidelines. Study Design: ...